SEC Separation of ADC Brentuximab Vedotin

April 30, 2021
YMC Europe GmbH

Sponsored Content

The antibody-drug conjugate was separated from its aggregates and fragments in only one run using a YMC-SEC MAB column and varying mobile phases.